The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Regeneration of B cell subsets after transient B cell depletion using anti‐CD20 antibodies in rheumatoid arthritis
Abstract
Objective: Transient B cell depletion with the monoclonal anti‐CD20 antibody rituximab has resulted in favorable clinical responses in patients with rheumatoid arthritis (RA). However, little is known about the regeneration profile of different peripheral B cell subpopulations. The aim of this study was to delineate the regeneration profile of different B cell subsets in the peripheral blood after selective anti‐CD20–mediated B cell depletion. Methods: Seventeen patients with RA refractory to standard therapy were treated with rituximab. Patients 1–6 received 4 weekly infusions of rituximab at a dose of 375 mg/m 2, and patients 7–17 received 2 infusions of rituximab (1,000 mg), 2 weeks apart. Four‐color staining was performed at several time points, using CD38, IgD, and CD27 in addition to other cell surface markers. In one patient, the mutational status of the immunoglobulin receptor was examined. Results: The analysis revealed a distinct pattern of B cell regeneration. The first wave of repopulating B cells were immature B cells (CD38 high,IgD+,CD10+,CD24 high), the immunoglobulin receptors of which were not yet somatically mutated. In parallel, a recirculation of plasma cells was observed. Later, the number of naive B cells increased, and these cells predominated in the peripheral blood B cell pool. CD27+ memory B cells showed a slow and delayed repopulation, and the level of these cells stayed significantly reduced (<50%) compared with baseline values, for more than 2 years. Conclusion: Our findings provide evidence for a characteristic regeneration pattern of B cell subpopulations, with long‐lasting modulation of B cell subset composition, after selective anti‐CD20–mediated B cell depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Klein, U., Rajewsky, K., & Küppers, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1679 · Cited by 1,154
van der Heijde, D. M., van 't Hof, M. A., van Riel, P. L., Theunisse, L. A., Lubberts, E. W., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.11.916 · Cited by 1,087
Weller, S. (2004) · Blood · doi:10.1182/blood-2004-01-0346 · Cited by 814
Wu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION
Janossy, G., Duke, O., Poulter, L. W., Panayi, G., Bofill, M., & Goldstein, G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91107-7 · Cited by 655
Analysis of somatic mutation in five B cell subsets of human tonsil.
Pascual, V, Liu, Y. J., Magalski, A., de Bouteiller, O., Banchereau, J., & Capra, J. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.329 · Cited by 648
Identification and characterization of circulating human transitional B cells
Sims, G. P., Ettinger, R., Shirota, Y., Yarboro, C. H., Illei, G. G., & Lipsky, P. E. (2005) · Blood · doi:10.1182/blood-2004-11-4284 · Cited by 604
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
Gong, Q., Ou, Q., Ye, S., Lee, W. P., Cornelius, J., Diehl, L., Lin, W. Y., Hu, Z., Lu, Y., Chen, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.817 · Cited by 543
Peripheral development of B cells in mouse and man
Carsetti, R., Rosado, M. M., & Wardmann, H. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0109.x · Cited by 473
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
Anolik, J. H., Barnard, J., Cappione, A., Pugh‐Bernard, A. E., Felgar, R. E., Looney, R. J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20592 · Cited by 456
Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
Agematsu, K., Hokibara, S., Nagumo, H., & Komiyama, A. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01605-4 · Cited by 412
Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?
Duddy, M. E., Alter, A., & Bar-Or, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3422 · Cited by 369
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
Leandro, M. J., Edwards, J. C. W., & Cambridge, G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.883 · Cited by 345
Bohnhorst, J. Ø., Bjørgan, M. B., Thoen, J. E., Natvig, J. B., & Thompson, K. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3610 · Cited by 321
A new CD21low B cell population in the peripheral blood of patients with SLE
Wehr, C., Eibel, H., Masilamani, M., Illges, H., Schlesier, M., Peter, H.-H., & Warnatz, K. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.010 · Cited by 308
Rituximab treatment results in impaired secondary humoral immune responsiveness
van der Kolk, L. E., Baars, J. W., Prins, M. H., & van Oers, M. H. J. (2002) · Blood · doi:10.1182/blood.v100.6.2257 · Cited by 284
Vita, S. D., Zaja, F., Sacco, S., Candia, A. D., Fanin, R., & Ferraccioli, G. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10467 · Cited by 251
Roles of B cells in rheumatoid arthritis.
Silverman, G. J., & Carson, D. A. (2003) · Arthritis Research · doi:10.1186/ar1010 · Cited by 190
Do self‐perpetuating B lymphocytes drive human autoimmune disease?
Edwards, Cambridge, & Abrahams (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00772.x · Cited by 174
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
Yamada, A., Salama, A. D., & Sayegh, M. H. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132559 · Cited by 174
Shi, Y., Agematsu, K., Ochs, H. D., & Sugane, K. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00092-5 · Cited by 159
Effective B Cell Depletion with Rituximab in the Treatment of Autoimmune Diseases
Kneitz, C. (2002) · Immunobiology · doi:10.1078/0171-2985-00200 · Cited by 140
Self-citationIdentification of early plasma cells in peripheral blood and their clinical significance
Harada, Y., Kawano, M. M., Huang, N., Mahmoud, M. S., Lisukov, I., Mihara, K., Tsujimoto, T., & Kuramoto, A. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.300835.x · Cited by 100
Rouzière, A., Kneitz, C., Palanichamy, A., Dörner, T., & Tony, H. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1731 · Cited by 54
Self-citationRùzicková, Š., Prüß, A., Odendahl, M., Wolbart, K., Burmester, G. R., Scholze, J., Dörner, T., & Hansen, A. (2002) · Blood · doi:10.1182/blood.v100.9.3419 · Cited by 46
Improvement of refractory rheumatoid arthritis after depletion of B cells
Kneitz, C., Wilhelm, M., & Tony, H. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310004379 · Cited by 38
Self-citationThe role of B cells in the pathogenesis of rheumatoid arthritis.
Kotzin, B. L. (2005) · PubMed · Cited by 36
Cited by
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Self-citationNew therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Cerutti, A., Cols, M., & Puga, I. (2013) · Nature Reviews Immunology · doi:10.1038/nri3383 · Cited by 777
Ofatumumab versus Teriflunomide in Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Cohen, J. A., Comi, G., Correale, J., Coyle, P. K., Cross, A. H., de Seze, J., Leppert, D., Montalban, X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917246 · Cited by 734
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Metadata
- Authors
- Roll, P., Palanichamy, A., Kneitz, C., Dorner, T., & Tony, H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-07-25
- Volume
- 54
- Issue
- 8
- Pages
- 2377-2386
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2077286174
- Cited by
- 321
- References
- 33
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.